Drug Trial Radar · NCT00333372
To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia
Last checked: Nov 19, 2026Latest source record: Jan 14, 2009 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
440
Actual
Start
Apr 2006
Primary completion
Not stated
Sponsor
- Lead sponsor
- Zeria PharmaceuticalIndustry
- Sponsor type
- Industry
- First posted
- Jun 5, 2006
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years, up to 79 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To Evaluate the efficacy of Z-338 in subjects with Functional Dyspepsia, focusing on the assessment of subjective symptoms in order to further determine the optimal dosage and efficacy parameters for PhaseIII clinical trials.
Conditions
- Functional Dyspepsia
Interventions
Z-338Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- General impression at last visit
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Tohoku University
Sendai, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.